Linde Hits Record $8.1 Billion Backlog on AI-Driven Electronics Boom, But U.S. Homecare Business Keeps Dragging Margins
Q2 2026 earnings call, July 31, 2026
Linde delivered near double-digit sales and EPS growth in the second quarter, but the headline story was less about the quarter itself than about where the next several years of growth are coming from — and what is still standing in the way of margin expansion. CEO Sanjiv Lamba announced the project backlog grew by $1 billion sequentially to a record $8.1 billion, driven by a new electronics win tied to advanced-node fab expansion in the western United States. Even after accounting for more than $1.3 billion of project start-ups expected in the second half, Lamba said he expects the sale-of-gas backlog to "finish the year with an 8 handle," a signal that the electronics pipeline remains deep enough to backfill conversions at an unusually fast pace.
Electronics Is Now the Growth Engine, With AI Hardware Demand Explicit
Electronics grew 18% year-over-year in the quarter and Lamba was direct about the driver: "Electronics is the fastest-growing end market with the combination of project start-ups and higher demand tied to hardware associated with AI." Beyond the U.S. backlog addition, Linde disclosed a separate $800 million investment through its Taiwan joint venture to build, own and operate air separation units and hydrogen production for new semiconductor fab and advanced packaging capacity — a deal that sits outside the reported backlog figure entirely. CFO Matt White added color on project economics, noting revenue-to-CapEx conversion for these wins ranges from 20% to 50% depending on whether the project involves atmospheric gases or process gases like hydrogen, but that returns are underwritten on a consistent unlevered IRR basis regardless of end market — meaning the electronics surge is not being chased at the expense of investment discipline.
Homecare Business Remains an Open Wound, Strategic Review Underway
The clearest disappointment in the quarter was the U.S. Lincare homecare business, which management confirmed is now under formal strategic review, "both in part and as a whole." White quantified the damage: the margin penalty from homecare was over $30 million in the quarter, roughly 30% higher than one analyst's estimate, implying a run rate approaching $150 million-plus annually. Excluding Lincare, Americas margins would have actually been up 20 basis points year-over-year rather than the reported decline. Lamba was candid about the root cause: "The business has served us well through the COVID period... but over the last couple of years, in particular, it has faced persistent headwinds from labor cost inflation and changes in reimbursement environment." Management has already installed new leadership and is pruning the portfolio, but Lamba stopped short of committing to a sale timeline, saying only that the company wants to "determine one way or the other" whether the business has "a meaningful positive impact" on the portfolio. Total operating margin excluding cost pass-through fell 30 basis points year-over-year, with White flagging additional dilution from higher U.S. hard goods sales and lower-margin electronics equipment sales in APAC — both of which management frames as positive leading indicators rather than structural problems, since equipment sales typically pull through higher-margin gas contracts over time.
Helium Supply Chain Navigated Strait of Hormuz Disruption, But Normalization Pushed to 2027
Linde's helium business has been managing the fallout from the Strait of Hormuz disruption, and Lamba struck a notably confident tone on execution: the company has maintained reliable supply to existing contracted customers while simultaneously signing new long-term contracts, leveraging diversified sourcing and logistics capability. Pricing has moved higher, but dislocation costs are offsetting the margin benefit for now. Critically, Lamba pushed back on any expectation of near-term normalization: "I don't think you will see normalization this year... it will probably take us into the early part of next year." The company left full-year guidance assumptions on helium unchanged, effectively assuming no material swing either way, and management indicated the interplay of volume and price mix next year makes it too early to call helium a clean tailwind for 2027.
Commercial Space Push Reshaping CapEx, Raising Make-Versus-Buy Questions
Linde's CapEx guidance increase for the year was partly attributed to expanded commercial space investment, and White offered a useful framework for how customer vertical integration is playing out. Certain space players with sufficient capital access are choosing to own atmospheric gas production given the sheer propellant volumes required, a dynamic White compared to how large industrial on-site customers have historically approached make-versus-buy decisions. Notably, this vertical integration trend is confined to atmospheric gases — White was explicit that "we are not seeing it in the hydrogen side, which is a very, very different dynamic for any hydrolox-based engines." Linde intends to participate regardless of structure, often through hybrid sale-of-plant-plus-operate-and-maintain arrangements. Separately, management reaffirmed its long-standing $1 billion-plus space market opportunity target by 2030, without providing an updated figure.
Guidance Nudged Up at the Low End, Management Explicitly Avoiding a Macro Call
Full-year EPS guidance was raised at the bottom end to $17.70–$17.90, representing 8% to 9% growth excluding a 1% FX tailwind, though the top of the range was left unchanged. Third-quarter guidance of $4.45 to $4.55 implies 6% to 8% growth. White reiterated that the guidance continues to assume no economic improvement at the midpoint, despite acknowledging "some recovery" in base volumes during the second quarter — management wants additional confirmation before building that into forward numbers. On the framework for 2027, Lamba reiterated the standing 8% to 12% EPS growth algorithm built from management actions and capital allocation, stating plainly, "we're not looking for macro," a point aimed at reinforcing the durability of Linde's earnings model independent of the broader industrial cycle. Management also flagged unspecified additional cost actions this quarter to get ahead of margin pressure, with more detail promised on the October call.